Histone deacetylases (HDAC) are overexpressed in many cancers including CLL, in which they mediate epigenetic silencing of miR-15a, miR-16 and miR-29b [56]. The gene discussed is HDAC9; the disease is B-cell chronic lymphocytic leukemia.